Epitalon vs IllumiNeuro Protocol
Well Studied vs Limited Research
compatible Complementary pineal/longevity support; different mechanisms.
Molecular Data
Epitalon IllumiNeuro Protocol
Weight 390.35 Da —
Half-life Not established (short peptide) —
Chain 4 amino acids —
Type Tetrapeptide Fixed-ratio peptide combination
Key Benefits
Epitalon
01 Telomere extension and cellular replicative lifespan extension
02 Enhanced melatonin production
03 Improved immune function
04 Potential lifespan extension (25-33% in animal studies)
05 Systemic anti-aging through cellular rejuvenation
06 Short cycle duration with long-lasting effects
IllumiNeuro Protocol
01 Multi-pathway cognitive enhancement
02 Neuroprotective and neuritogenic effects
03 Anxiolytic properties from NA-Selank
04 BDNF upregulation from NA-Semax
05 Circadian/sleep support from Pinealon
06 Convenience of single injection
07 Extended-action amidate forms included
Dosing Protocols
Epitalon
100-500mcg per injection / Once daily for 10-20 consecutive days
Standard anti-aging 200-500mcg 1x daily for 10-20 days
Conservative start 100mcg 1x daily for 10-20 days
Russian clinical equivalent 300mcg 1x daily for 10-20 days
Ultra-low dose 50mcg 1x daily for 10-20 days
IllumiNeuro Protocol
100-500 mcg total blend per day / Once daily, preferably in the morning for cognitive benefits
Conservative cognitive support 100-200mcg total blend Once daily (morning)
Standard protocol 200-400mcg total blend Once daily
Enhanced protocol 400-500mcg total blend Once daily
Side Effects
Epitalon
Generally well-tolerated with minimal side effects
Mild injection site reactions
Vivid dreams (melatonin-related)
Possible mild digestive upset (oral route)
IllumiNeuro Protocol
Injection site reactions (mild)
Nasal irritation if used intranasally
Possible vivid dreams (Pinealon effect)
Mild headache initially
Contraindications
Active malignancy (telomerase activation concern)
Chronic sinusitis (nasal route)
Known peptide allergies
Pregnancy or breastfeeding
No clinical trials on four-peptide combination
Bipolar disorder or psychosis (caution with cognitive enhancers)
Pregnancy or breastfeeding
Seizure disorders (theoretical concern)
Research Evidence
Epitalon IllumiNeuro Protocol
Status Well Studied Limited Research
References 6 studies 4 studies
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.